Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Women scientists receive $41,000 less in funding than men, study shows

March 6, 2019 Research and Development NIH, funding, international womens day, management, science, women

Women scientists receive $41,000 less in federal funding than men, according to a study of nearly 54,000 grants to first …
News
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …
Appointment
novartis_side_building

Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial

March 5, 2019 Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …
News

The cutting edge of cancer research

March 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …
News
8b437d43644106a4fb11aa4292aa6fbd_1

Working Life: Nicola Redfern, UK General Manager, bluebird bio

February 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, Interview, Working Life, pharma

How did you find your way into the pharma industry? Was it always an aspiration of yours? My mum worked …
Feature
medicinal_cannabis_uk_review

Scientists genetically modify yeast to produce CBD and THC

February 28, 2019 Research and Development Medical marijuana, berkely, cannabis, science, yeast

Researchers at the University of California, Berkeley have genetically modified brewer’s yeast so that it produces two common cannabinoids: tetrahydrocannabinol …
News
ecstasy

Patients to recieve MDMA-assisted psychotherapy on ‘compassionate’ grounds in Israel

February 28, 2019 Research and Development MDMA, PTSD, drugs, mental health, psychedelics

The Israeli Health Ministry has approved the compassionate use of MDMA-assisted psychotherapy for 50 patients with post-traumatic stress disorder (PTSD). …
News
ritalin-sr-20mg-1000x1000

Darknet sales of prescription psychiatric drugs increasing in the UK

February 27, 2019 Research and Development, Sales and Marketing King's College London, Kings College London, University of Kent, darknet, pharma

Research from the University of Kent and King’s College London has revealed that UK sales of prescription psychiatric drugs, including …
News

Vaccine biotech Emergex name experienced pharma professional Dr Athanasios Papadopoulos as new CMO

February 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Emergex Vaccine Holdings Limited has named Dr Athanasios Papadopoulos as the company’s new Chief Medical Officer (CMO). The appointment, effective …
Appointment
senatefloor

Pharma execs testify in front of Senate of rising drug prices

February 27, 2019 Research and Development Business, Senate hearing, USA, pharma, sfc

Senior Executives from seven major pharmaceutical companies, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi and Johnson & …
News

Sanofi’s Dupixent improves symptoms in rhinosinusitis with nasal polyps at Phase 3

February 27, 2019 Research and Development Dupixent, Sanofi, pharma, rhinosinusitis

New data has been released on Sanofi’s Dupixent (dupilumab), derived from two Phase 3 trials, illustrating the drug’s efficacy In …
News
parkinsons_device_passion_productions

British scientist develops technology able to deliver drugs directly into the brain

February 27, 2019 Research and Development device, medical technology, neurology, neuroscince, parkinson's cns

A British scientist has developed innovative technology that is able to deliver drugs deep into the brain in order to …
News
patrick_chinnery

Professor Patrick Chinnery named as Clinical Director of MRC

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Patrick Chinnery has been appointed to the role of Clinical Director at the Medical Research Council (MRC) the non-departmental …
Appointment
pharmafocus_march_2019_cover

Read the March 2019 issue of Pharmafocus online now!

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease

Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026